{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:09:39Z","timestamp":1790633379627,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cmi.2022.05.014","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T23:04:39Z","timestamp":1653606279000},"page":"1477-1485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The association between pre-exposure to glucocorticoids and other immunosuppressant drugs with severe COVID-19 outcomes"],"prefix":"10.1016","volume":"28","author":[{"given":"Rakel","family":"Brodin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzannes Desir\u00e9e","family":"van der Werff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontus","family":"Hedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"F\u00e4rnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontus","family":"Naucl\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Requena-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2022.05.014_bib2","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2022.05.014_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2022.05.014_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/cid\/ciaa863","article-title":"COVID-19 in immunocompromised hosts: what we know so far","volume":"72","author":"Fung","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2022.05.014_bib5","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/bcp.14622","article-title":"Hospitalization for COVID-19 in patients treated with selected immunosuppressant and immunomodulating agents, compared to the general population: a Danish cohort study","volume":"84","author":"N\u00f8rg\u00e5rd","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cmi.2022.05.014_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/joim.13172","article-title":"Clinical characteristics and outcomes of immunosuppressed patients hospitalized with COVID-19: experience from London","volume":"289","author":"Vaid","year":"2021","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cmi.2022.05.014_bib7","doi-asserted-by":"crossref","first-page":"e4124","DOI":"10.1093\/cid\/ciaa1488","article-title":"Association between chronic use of immunosuppressive drugs and clinical outcomes from Coronavirus Disease 2019 (COVID-19] hospitalization: a retrospective cohort study in a large US health system","volume":"73","author":"Andersen","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2022.05.014_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10875-020-00927-y","article-title":"The impact of immunosuppression and autoimmune disease on severe outcomes in patients hospitalized with COVID-19","volume":"41","author":"Monreal","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.cmi.2022.05.014_bib9","author":"World Health Organization"},{"key":"10.1016\/j.cmi.2022.05.014_bib10","first-page":"1138","article-title":"Acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.cmi.2022.05.014_bib11","author":"Hulting"},{"key":"10.1016\/j.cmi.2022.05.014_bib12","author":"Nelson Kotton"},{"key":"10.1016\/j.cmi.2022.05.014_bib13","author":"Folkh\u00e4lsomyndigheten"},{"key":"10.1016\/j.cmi.2022.05.014_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/eci.12386","article-title":"Transient cardiac injury during H7N9 infection","volume":"45","author":"Han","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cmi.2022.05.014_bib15","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1378\/chest.10-0032","article-title":"Reversible cardiac dysfunction associated with pandemic 2009in\ufb02uenza a(h1n1)","volume":"137","author":"Martin","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2022.05.014_bib16","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S1470-2045(20)30309-0","article-title":"Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study","volume":"21","author":"Tian","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cmi.2022.05.014_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S2352-3018(20)30164-8","article-title":"Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort","volume":"7","author":"Vizcarra","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.cmi.2022.05.014_bib18","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/j.transproceed.2020.07.014","article-title":"Coronavirus disease 2019 in immunocompromised organ transplant recipients: a case report and review of the literature","volume":"52","author":"Taha","year":"2020","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cmi.2022.05.014_bib19","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/tri.13662","article-title":"COVID-19 in solid organ transplant recipients: a single-center experience","volume":"33","author":"Hoek","year":"2020","journal-title":"Transpl Int"},{"key":"10.1016\/j.cmi.2022.05.014_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/acr.21812","article-title":"Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis","volume":"65","author":"Widdifield","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.cmi.2022.05.014_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","article-title":"Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry","volume":"159","author":"Brenner","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmi.2022.05.014_bib22","first-page":"2100769","article-title":"The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection","author":"Ward","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2022.05.014_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MD.0b013e3182a72299","article-title":"Glucocorticoid therapy and the risk of infection in patients with newly diagnosed autoimmune disease","volume":"92","author":"Migita","year":"2013","journal-title":"Medicine"},{"key":"10.1016\/j.cmi.2022.05.014_bib24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1185\/03007995.2013.818531","article-title":"What do we know about the safety of corticosteroids in rheumatoid arthritis?","volume":"29","author":"Ethgen","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cmi.2022.05.014_bib25","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1097\/TXD.0000000000001292","article-title":"Immunosuppression and SARS-CoV-2 infection in kidney transplant recipients","volume":"8","author":"Devresse","year":"2022","journal-title":"Transplant Direct"},{"key":"10.1016\/j.cmi.2022.05.014_bib26","doi-asserted-by":"crossref","first-page":"e0255524","DOI":"10.1371\/journal.pone.0255524","article-title":"In-hospital mortality among immunosuppressed patients with COVID-19: analysis from a national cohort in Spain","volume":"16","author":"Su\u00e1rez-Garc\u00eda","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2022.05.014_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13054-017-1767-1","article-title":"Association of baseline steroid use with long-term rates of infection and sepsis in the REGARDS cohort","volume":"21","author":"Chaudhary","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2022.05.014_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rdc.2015.08.004","article-title":"Infection risk and safety of corticosteroid use","volume":"42","author":"Youssef","year":"2016","journal-title":"Rheum Dis Clin North Am"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22002701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22002701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:32:35Z","timestamp":1761118355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X22002701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1198743X22002701"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2022.05.014","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between pre-exposure to glucocorticoids and other immunosuppressant drugs with severe COVID-19 outcomes","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2022.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}